Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting

被引:41
作者
Manosuthi, Weerawat
Chaovavanich, Achara
Tansuphaswadikul, Somsit
Prasithsirikul, Wisit
Inthong, Yoawarat
Chottanapund, Suthat
Sittibusaya, Chayanan
Moolasart, Visal
Termvises, Patamavadee
Sungkanuparph, Somnuek
机构
[1] Minist Publ Hlth, Dept Med, Bamrasnaradura Infect Dis Inst, Nonthaburi 11000, Thailand
[2] Mahidol Univ, Fac Med Ramathibodi Hosp, Bangkok 10400, Thailand
关键词
HIV; opportunistic infections; tuberculosis; antiretroviral therapy; incidence; risk factors; immune reconstitution;
D O I
10.1016/j.jinf.2007.07.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To study incidence, risk factors, and impact of major opportunistic infections (OIs) after initiation of antiretroviral therapy (ART). Methods: A retrospective cohort study was conducted among naive HIV-infected patients who were initiated ART during January 2003-December 2004. All patients were followed until 15 months after ART. Results: There were 793 patients with mean +/- SD age of 35.2 +/- 7.4 years and 56.3% male. Median (IQR) CD4 was 26 (9-78) cells/mm(3). Of 793 patients, 61 (8%) patients developed 81 episodes of OIs after ART. These included tuberculosis (48.1%), CMV retinitis (19.8%), MAC infection (14.8%), PCP (9.9%), cryptococcosis (6.2%) and penicilliosis (1.2%). Overall incidence of new episode of OIs after ART was 8.0% during the first year of ART. Probabilities of OIs at 1, 2, 3, 6, and 12 months after ART were 2.6%, 4.0%, 5.3%, 6.9% and 8.0%, respectively. Baseline CD4 <= 50 cells/ mm(3), male gender, and low body weight were associated with higher incidence of OIs after ART (P < 0.05). Conclusions: Most of new episodes of major OIs develop within the first three months after ART. Tuberculosis is the most frequent OIs in this situation. The substantial increase of new episode of OIs after ART was observed among HIV-infected patients with CD4 cell counts <= 50 cells/mm(3) at ART initiation. (c) 2007 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:464 / 469
页数:6
相关论文
共 26 条
[1]   Nutrition and infectious diseases in developing countries and problems of acquired immunodeficiency syndrome [J].
Ambrus, JL ;
Ambrus, JL .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2004, 229 (06) :464-472
[2]   Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study [J].
Badri, M ;
Wilson, D ;
Wood, R .
LANCET, 2002, 359 (9323) :2059-2064
[3]  
Badri M, 2001, INT J TUBERC LUNG D, V5, P225
[4]   Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level [J].
Bates, I ;
Fenton, C ;
Gruber, J ;
Lalloo, D ;
Lara, AM ;
Squire, SB ;
Theobald, S ;
Thomson, R ;
Tolhurst, R .
LANCET INFECTIOUS DISEASES, 2004, 4 (05) :267-277
[5]  
Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2
[6]   Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort [J].
Calmy, Alexandra ;
Pinoges, Lorextu ;
Szumilin, Elisabeth ;
Zachariah, Rony ;
Ford, Nathan ;
Ferradini, Laurent .
AIDS, 2006, 20 (08) :1163-1169
[7]   Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy [J].
Carcelain, G ;
Debré, P ;
Autran, B .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (04) :483-488
[8]   The growing burden of tuberculosis - Global trends and interactions with the HIV epidemic [J].
Corbett, EL ;
Watt, CJ ;
Walker, N ;
Maher, D ;
Williams, BG ;
Raviglione, MC ;
Dye, C .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (09) :1009-1021
[9]   Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study [J].
Egger, M ;
Hirschel, B ;
Francioli, P ;
Sudre, P ;
Wirz, M ;
Flepp, M ;
Rickenbach, M ;
Malinverni, R ;
Vernazza, P ;
Battegay, M ;
Bernasconi, E ;
Burgisser, P ;
Erb, P ;
Fierz, W ;
Grob, P ;
Gruninger, U ;
Jeannerod, L ;
Ledergerber, B ;
Luthy, R ;
Matter, L ;
Opravil, M ;
Paccaud, F ;
Perrin, L ;
Pichler, W ;
Piffaretti, GC ;
Rutschmann, O ;
Zanetti, G .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7117) :1194-1199
[10]  
JON F, 2004, TUBERCULOSIS